Labor, Michelle .
HRN: 28-62-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
CEFUROXIME 500MG (TAB)
02/28/2026
03/06/2026
ORAL
500mg
BID
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: